Veterinary PoC Diagnostics Market by Product (Consumables and Instruments), Technology [Immunodiagnostics, Molecular Diagnostics (Isothermal Amplification, PCR, CRISPR)], Animal Type (Companion Animals, Livestock, Poultry) - Global Forecast to 2031
The veterinary PoC diagnostics market is expected to grow from USD 1.19 billion in 2026 to USD 1.72 billion by 2031, at a CAGR of 7.7%. This growth is driven by several key factors shaping the future of rapid veterinary diagnostics, decentralized testing, and real-time animal health management.
The veterinary PoC diagnostics market is primarily driven by increasing focus on disease identification at the point of care in companion and farm animals, fueling the need for rapid clinical decision-making. The growing trend of pet ownership and livestock intensification is pushing veterinarians and animal health service providers to emphasize early detection and regular health monitoring, helping them reduce the disease burden and improve treatment management. Consequently, veterinary clinics, farms and field veterinarians are increasingly employing point-of-care instruments such as rapid immunoassays, portable molecular systems, and handheld analyzers for rapid disease identification.
Another key driver is the growing focus on animal health prevention, biosecurity and management of zoonotic and economically important diseases. Governments, veterinary associations, and animal owners are placing greater focus on disease monitoring and surveillance to reduce the number of disease outbreaks and safeguard food safety and public health. This is increasing the demand for PoC testing for rapid disease detection and treatment decision-making.
In addition, while the current PoC diagnostic market is still in development, improvements in diagnostic technology, in particular smaller and more portable diagnostic devices, isothermal amplification techniques, and integrated digital platforms, are improving the potency and viability of PoC diagnostic tools. Developments including cartridge-based approaches, ready-to-use diagnostic kits, and connected diagnostic devices will greatly reduce testing times, automate processes, and make the wider use of PoC diagnostics more feasible.
By animal type, companion animals to record higher CAGR during forecast period
The companion animals segment is expected to witness a higher growth rate in the veterinary PoC diagnostics market due to the rising global pet population and increasing humanization of pets, leading to higher spending on advanced veterinary care. Pet owners are increasingly demanding rapid, in-clinic diagnostics for early disease detection and immediate treatment decisions, driving adoption of PoC technologies in veterinary clinics. Additionally, greater awareness of preventive healthcare, frequent veterinary visits, and the availability of advanced, user-friendly diagnostic solutions tailored for companion animals are further accelerating growth in this segment.
By technology, immunodiagnostics segment accounted for largest market share in 2025
In 2025, the immunodiagnostics segment dominated the veterinary PoC diagnostics market due to its widespread use in rapid, easy-to-perform testing formats such as lateral flow assays and ELISA-based kits. These tests are commonly used to detect infectious diseases, parasites, and biomarkers across both companion and livestock animals, making them integral to routine veterinary practice. Their advantages, including quick turnaround time, cost-effectiveness, minimal sample preparation, and suitability for in-clinic and field settings without advanced infrastructure, drive high adoption volumes and make immunodiagnostics the dominant segment in the market.
Asia Pacific to witness highest growth rate during forecast period
The Asia Pacific region is growing at the fastest rate in the veterinary PoC diagnostics market. The main reason for this is due to rising livestock production, pet ownership, and awareness of animal health management in emerging countries of the region. Pet adoption is increasing in many emerging nations, coupled with the rising use of portable, rapid diagnostic products in clinical and farm settings due to expanding veterinary infrastructure and government initiatives for disease surveillance and control. The growing incidence of infectious and zoonotic diseases and an increase in investments by global and regional players are leading to the wide adoption of portable, user-friendly veterinary PoC diagnostics.
Breakdown of supply-side primary interviews:
Other designations include sales, marketing, and product managers.
Breakdown of demand-side primary interviews:
Note: Other designations include laboratory technicians, practice managers, procurement officers, and academic researchers.
Research Coverage
The market study covers the veterinary PoC diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
The veterinary PoC diagnostics market is primarily driven by increasing focus on disease identification at the point of care in companion and farm animals, fueling the need for rapid clinical decision-making. The growing trend of pet ownership and livestock intensification is pushing veterinarians and animal health service providers to emphasize early detection and regular health monitoring, helping them reduce the disease burden and improve treatment management. Consequently, veterinary clinics, farms and field veterinarians are increasingly employing point-of-care instruments such as rapid immunoassays, portable molecular systems, and handheld analyzers for rapid disease identification.
Another key driver is the growing focus on animal health prevention, biosecurity and management of zoonotic and economically important diseases. Governments, veterinary associations, and animal owners are placing greater focus on disease monitoring and surveillance to reduce the number of disease outbreaks and safeguard food safety and public health. This is increasing the demand for PoC testing for rapid disease detection and treatment decision-making.
In addition, while the current PoC diagnostic market is still in development, improvements in diagnostic technology, in particular smaller and more portable diagnostic devices, isothermal amplification techniques, and integrated digital platforms, are improving the potency and viability of PoC diagnostic tools. Developments including cartridge-based approaches, ready-to-use diagnostic kits, and connected diagnostic devices will greatly reduce testing times, automate processes, and make the wider use of PoC diagnostics more feasible.
By animal type, companion animals to record higher CAGR during forecast period
The companion animals segment is expected to witness a higher growth rate in the veterinary PoC diagnostics market due to the rising global pet population and increasing humanization of pets, leading to higher spending on advanced veterinary care. Pet owners are increasingly demanding rapid, in-clinic diagnostics for early disease detection and immediate treatment decisions, driving adoption of PoC technologies in veterinary clinics. Additionally, greater awareness of preventive healthcare, frequent veterinary visits, and the availability of advanced, user-friendly diagnostic solutions tailored for companion animals are further accelerating growth in this segment.
By technology, immunodiagnostics segment accounted for largest market share in 2025
In 2025, the immunodiagnostics segment dominated the veterinary PoC diagnostics market due to its widespread use in rapid, easy-to-perform testing formats such as lateral flow assays and ELISA-based kits. These tests are commonly used to detect infectious diseases, parasites, and biomarkers across both companion and livestock animals, making them integral to routine veterinary practice. Their advantages, including quick turnaround time, cost-effectiveness, minimal sample preparation, and suitability for in-clinic and field settings without advanced infrastructure, drive high adoption volumes and make immunodiagnostics the dominant segment in the market.
Asia Pacific to witness highest growth rate during forecast period
The Asia Pacific region is growing at the fastest rate in the veterinary PoC diagnostics market. The main reason for this is due to rising livestock production, pet ownership, and awareness of animal health management in emerging countries of the region. Pet adoption is increasing in many emerging nations, coupled with the rising use of portable, rapid diagnostic products in clinical and farm settings due to expanding veterinary infrastructure and government initiatives for disease surveillance and control. The growing incidence of infectious and zoonotic diseases and an increase in investments by global and regional players are leading to the wide adoption of portable, user-friendly veterinary PoC diagnostics.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
- By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
- By Region: North America (40%), Europe (25%), Asia Pacific (20%), Latin America (10%), and the Middle East & Africa (5%)
Other designations include sales, marketing, and product managers.
Breakdown of demand-side primary interviews:
- By End User: Veterinary Hospitals & Clinics (50%), Homecare Settings (35%), Other End Users (15%)
- By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)
Note: Other designations include laboratory technicians, practice managers, procurement officers, and academic researchers.
Research Coverage
The market study covers the veterinary PoC diagnostics market in various segments. It aims to estimate the market size and growth potential of this market by product, technology, animal type, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
- Analysis of key drivers (rising demand for rapid, on-site diagnosis and immediate clinical decision-making, increasing pet ownership and intensification of livestock production), restraints (limited sensitivity/accuracy compared to centralized laboratory testing in some cases, high cost of advanced PoC devices and limited adoption in low-income regions), opportunities (technological advancements in portable molecular diagnostics and biosensors, growing adoption in emerging markets with expanding veterinary infrastructure), and challenges (lack of standardization and regulatory variations across regions, limited skilled professionals for proper use and interpretation of PoC tests) influencing the growth of the veterinary PoC diagnostics market
- Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the veterinary PoC diagnostics market
- Market Development: Comprehensive information about lucrative emerging markets by analyzing the markets for various types of PoC diagnostic products across regions
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the veterinary PoC diagnostics market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the veterinary PoC diagnostics market
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.3.5 UNIT CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN VETERINARY POC DIAGNOSTICS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 VETERINARY POC DIAGNOSTICS MARKET OVERVIEW
3.2 VETERINARY POC DIAGNOSTICS MARKET IN ASIA PACIFIC, BY PRODUCT AND COUNTRY
3.3 VETERINARY POC DIAGNOSTICS MARKET: REGIONAL MIX
3.4 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.5 VETERINARY POC DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising incidence of transboundary and endemic diseases
4.2.1.2 Increasing demand for animal-derived food products
4.2.1.3 Technological advancements in molecular diagnostics, multiplex assays, and rapid testing platforms
4.2.1.4 Growth in companion animal population
4.2.1.5 Rising demand for pet insurance and growing animal health expenditure
4.2.2 RESTRAINTS
4.2.2.1 Rising pet care costs
4.2.2.2 High cost of veterinary diagnostic tests
4.2.2.3 Limited diagnostic infrastructure in emerging economies
4.2.3 OPPORTUNITIES
4.2.3.1 Integration of AI & ML in veterinary PoC diagnostics
4.2.3.2 Expansion of rapid PoC and portable on-farm diagnostic solutions
4.2.4 CHALLENGES
4.2.4.1 Rapid mutation and strain variability of viral pathogens
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN VETERINARY POC DIAGNOSTICS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025
5.5.1.1 Pricing trend of veterinary PoC diagnostic products, by key player, 2023?2025
5.5.2 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY REGION, 2023–2025
5.5.2.1 Pricing trend of PCR kits, by region, 2023?2025
5.5.2.2 Pricing trend of immunodiagnostic veterinary POC products, by region, 2023?2025
5.6 TRADE ANALYSIS
5.6.1 TRADE DATA FOR HS CODE 3822-COMPLIANT PRODUCTS
5.6.1.1 Country-wise import data for HS code 3822-compliant products, 2021–2025
5.6.1.2 Country-wise export data for HS code 3822-compliant products, 2021–2025
5.7 KEY CONFERENCES AND EVENTS, 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 USE OF AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION
5.10.2 ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION
5.10.3 DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION
5.11 IMPACT OF US TARIFFS ON VETERINARY POC DIAGNOSTICS MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.5 IMPACT ON END USERS
5.11.5.1 Veterinary hospitals & clinics
5.11.5.2 Livestock producers & animal health networks
5.11.5.3 Home care settings
5.11.5.4 Other end users (mobile veterinary service providers, animal shelters, NGOs)
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY/EMERGING TECHNOLOGIES
6.1.1 CRISPR-BASED MOLECULAR DIAGNOSTICS
6.1.2 ISOTHERMAL AMPLIFICATION AND PAPER-BASED LAMP
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 MICROFLUIDICS & LAB-ON-A-CHIP DEVICES
6.2.2 BIOSENSOR-BASED DIAGNOSTIC SYSTEMS
6.3 ADJACENT TECHNOLOGIES
6.3.1 AI & MACHINE LEARNING
6.3.2 WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 NEAR TERM (2025–2027)
6.4.2 MID TERM (2028–2030)
6.4.3 LONG TERM (2030+)
6.5 PATENT ANALYSIS
6.5.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
6.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 PRECISION FLOCK-LEVEL DISEASE PREDICTION
6.6.2 MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS
6.6.3 MULTIPLEX AND SYNDROMIC VETERINARY DIAGNOSTIC PANELS
6.6.4 SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING
6.7 IMPACT OF AI/GENERATIVE AI ON VETERINARY POC DIAGNOSTICS MARKET
6.7.1 INTRODUCTION
6.7.2 MARKET POTENTIAL IN VETERINARY POC DIAGNOSTIC ECOSYSTEM
6.7.3 AI USE CASES
6.7.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY POC DIAGNOSTICS MARKET
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY ANALYSIS
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
7.2.2 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.3.1 UNMET NEEDS OF VARIOUS END USERS
8.4 MARKET PROFITABILITY
9 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 CONSUMABLES
9.2.1 INCREASING PREVALENCE OF INFECTIOUS AND ZOONOTIC DISEASES IN ANIMALS TO BOOST DEMAND
9.2.2 GLOBAL VOLUME ANALYSIS OF CONSUMABLES, 2024–2031 (THOUSAND UNITS)
9.3 INSTRUMENTS
9.3.1 SURGING DEMAND FOR PORTABLE AND AUTOMATED DIAGNOSTIC SYSTEMS TO ACCELERATE MARKET GROWTH
9.3.2 GLOBAL VOLUME ANALYSIS OF INSTRUMENTS, 2024–2031 (THOUSAND UNITS)
10 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE
10.1 INTRODUCTION
10.2 COMPANION ANIMALS
10.2.1 GROWING PET ADOPTION DUE TO RISING URBANIZATION TO FACILITATE MARKET GROWTH
10.2.2 DOG
10.2.2.1 Increasing prevalence of canine infectious diseases to support rapid adoption of veterinary care
10.2.3 CAT
10.2.3.1 Growing awareness of feline infectious diseases to fuel market growth
10.2.4 HORSE
10.2.4.1 Need to prevent vertical pathogen transmission to stimulate use of extensive PCR surveillance solutions
10.2.5 OTHER COMPANION ANIMALS
10.3 LIVESTOCK
10.3.1 SUSCEPTIBILITY OF LIVESTOCK TO FOOT-AND-MOUTH DISEASE, CLASSICAL SWINE FEVER, AVIAN INFLUENZA TO PROMOTE ADOPTION OF DIAGNOSTIC PRODUCTS
10.3.2 CATTLE
10.3.2.1 Increasing focus on improving milk quality, herd productivity, and biosecurity management to drive demand
10.3.3 PIG
10.3.3.1 Growing swine disease outbreaks to accelerate diagnostic utilization
10.3.4 POULTRY
10.3.4.1 Rrising concerns regarding zoonotic disease transmission to spur demand
10.3.5 OTHER LIVESTOCK
11 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY
11.1 INTRODUCTION
11.2 IMMUNODIAGNOSTICS
11.2.1 PRESSING NEED FOR RAPID AND COST-EFFECTIVE INFECTIOUS DISEASE TESTING TO CONTRIBUTE TO MARKET GROWTH
11.3 MOLECULAR DIAGNOSTICS
11.3.1 PCR-BASED
11.3.1.1 Increasing use of portable and multiplex PCR platforms to propel market
11.3.2 ISOTHERMAL AMPLIFICATION
11.3.2.1 Demand for rapid and low-infrastructure molecular testing to accelerate adoption
11.3.3 CRISPR-BASED
11.3.3.1 Emerging next-generation pathogen detection technologies to create growth potential
11.4 OTHER TECHNOLOGIES
12 VETERINARY POC DIAGNOSTICS MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.2.3 US
12.2.3.1 High veterinary healthcare expenditure to drive market
12.2.4 CANADA
12.2.4.1 Growing pet adoption to drive market
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.3.3 GERMANY
12.3.3.1 Rising awareness of zoonotic diseases to fuel market growth
12.3.4 UK
12.3.4.1 Increasing pet ownership to stimulate demand
12.3.5 FRANCE
12.3.5.1 Willingness of pet owners to spend on pet health to promote market growth
12.3.6 ITALY
12.3.6.1 Growing consumption of meat and dairy products to drive market
12.3.7 SPAIN
12.3.7.1 Growing demand for poultry products to fuel market growth
12.3.8 NETHERLANDS
12.3.8.1 Developments in veterinary diagnostic products to support market growth
12.3.9 POLAND
12.3.9.1 Rapid expansion of poultry production and export-oriented farming to elevate demand
12.3.10 SWEDEN
12.3.10.1 Strong veterinary healthcare infrastructure and advanced animal welfare regulations to propel market
12.3.11 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.4.3 CHINA
12.4.3.1 Increasing incidence of zoonotic diseases to propel market
12.4.4 JAPAN
12.4.4.1 Increasing pet expenditure to support market growth
12.4.5 INDIA
12.4.5.1 Increasing demand for dairy products to drive market
12.4.6 AUSTRALIA
12.4.6.1 Rise in pet ownership to support market growth
12.4.7 SOUTH KOREA
12.4.7.1 Rising need for specialized veterinary services to drive market
12.4.8 NEW ZEALAND
12.4.8.1 Focus on pet insurance to aid market
12.4.9 THAILAND
12.4.9.1 Growing focus on disease surveillance to drive market
12.4.10 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.5.3 BRAZIL
12.5.3.1 Booming livestock industry to boost demand
12.5.4 MEXICO
12.5.4.1 Expanding poultry sector to support market growth
12.5.5 ARGENTINA
12.5.5.1 Expanding poultry production and increasing focus on disease monitoring to drive market
12.5.6 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.6.3 GCC COUNTRIES
12.6.3.1 Kingdom of Saudi Arabia (KSA)
12.6.3.1.1 Technology advancements in veterinary diagnostics to boost demand
12.6.3.2 United Arab Emirates (UAE)
12.6.3.2.1 Favorable government support for vet diagnostics to drive market
12.6.3.3 Rest of GCC Countries
12.6.4 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, JANUARY 2022–APRIL 2026
13.3 REVENUE ANALYSIS, 2021?2025
13.4 MARKET SHARE ANALYSIS, 2025
13.4.1 US MARKET SHARE ANALYSIS, 2025
13.4.2 EUROPE MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Product footprint
13.5.5.4 Technology footprint
13.5.5.5 Animal type footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 BRAND/PRODUCT COMPARISON
13.8 R&D EXPENDITURE OF KEY PLAYERS
13.9 COMPANY VALUATION AND FINANCIAL METRICS
13.9.1 FINANCIAL METRICS
13.9.2 COMPANY VALUATION
13.10 COMPETITIVE SCENARIO
13.10.1 PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
13.10.2 DEALS
13.10.3 EXPANSIONS
13.10.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 IDEXX LABORATORIES, INC.
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches/Approvals/Enhancements
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 ZOETIS SERVICES LLC
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Deals
14.1.2.3.2 Expansions
14.1.2.3.3 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Key strengths
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 THERMO FISHER SCIENTIFIC INC.
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 MnM view
14.1.3.3.1 Key strengths
14.1.3.3.2 Strategic choices
14.1.3.3.3 Weaknesses & competitive threats
14.1.4 ANTECH DIAGNOSTICS, INC.
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches/Approvals/Enhancements
14.1.4.3.2 Expansions
14.1.4.4 MnM view
14.1.4.4.1 Key strengths
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 BIONOTE
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.4 Product launches/Approvals/Enhancements
14.1.5.4.1 Deals
14.1.5.5 MnM view
14.1.5.5.1 Key strengths
14.1.5.5.2 Strategic choices
14.1.5.5.3 Weaknesses & competitive threats
14.1.6 INNOVATIVE DIAGNOSTICS
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Other developments
14.1.7 BIOM?RIEUX
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches/Approvals/Enhancements
14.1.8 INDICAL BIOSCIENCE GMBH
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches/Approvals/Enhancements
14.1.9 VIRBAC
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Deals
14.1.9.3.2 Expansions
14.1.10 MEGACOR DIAGNOSTIK GMBH
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches/Approvals/Enhancements
14.1.11 BIOGAL
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 RING BIOTECHNOLOGY CO., LTD.
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches/Approvals/Enhancements
14.1.12.3.2 Other developments
14.1.13 AGROLABO S.P.A.
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 ENALEES
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.14.3 Recent developments
14.1.14.3.1 Product launches/Approvals/Enhancements
14.1.14.3.2 Deals
14.1.14.3.3 Expansions
14.1.14.3.4 Other developments
14.1.15 BIOPANDA REAGENTS LTD
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER PLAYERS
14.2.1 FASSISI, GMBH
14.2.2 SKYER, INC.
14.2.3 GOLD STANDARD DIAGNOSTICS
14.2.4 BIO-X DIAGNOSTICS S.A.
14.2.5 AFFIGEN INC.
14.2.6 ALVEO TECHNOLOGIES
14.2.7 FLUXERGY INC.
14.2.8 WOODLEY EQUIPMENT COMPANY LTD
14.2.9 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.
14.2.10 CORIS BIOCONCEPT
15 RESEARCH METHODOLOGY
15.1 RESEARCH APPROACH
15.2 RESEARCH METHODOLOGY DESIGN
15.2.1 SECONDARY RESEARCH
15.2.1.1 Key data from secondary sources
15.2.2 PRIMARY DATA
15.2.2.1 Key data from primary sources
15.2.2.2 Key industry insights
15.3 MARKET SIZE ESTIMATION
15.3.1 BOTTOM-UP APPROACH
15.4 DATA TRIANGULATION
15.5 MARKET SHARE ESTIMATION
15.6 RESEARCH ASSUMPTIONS
15.7 RESEARCH LIMITATIONS
15.7.1 METHODOLOGY-RELATED LIMITATIONS
15.7.2 SCOPE-RELATED LIMITATIONS
15.8 RISK ASSESSMENT
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.3.1 PRODUCT ANALYSIS
16.3.2 COMPANY INFORMATION
16.3.3 GEOGRAPHIC ANALYSIS
16.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
16.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT TYPE
16.3.6 BY PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
16.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.3.5 UNIT CONSIDERED
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN VETERINARY POC DIAGNOSTICS MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 VETERINARY POC DIAGNOSTICS MARKET OVERVIEW
3.2 VETERINARY POC DIAGNOSTICS MARKET IN ASIA PACIFIC, BY PRODUCT AND COUNTRY
3.3 VETERINARY POC DIAGNOSTICS MARKET: REGIONAL MIX
3.4 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
3.5 VETERINARY POC DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Rising incidence of transboundary and endemic diseases
4.2.1.2 Increasing demand for animal-derived food products
4.2.1.3 Technological advancements in molecular diagnostics, multiplex assays, and rapid testing platforms
4.2.1.4 Growth in companion animal population
4.2.1.5 Rising demand for pet insurance and growing animal health expenditure
4.2.2 RESTRAINTS
4.2.2.1 Rising pet care costs
4.2.2.2 High cost of veterinary diagnostic tests
4.2.2.3 Limited diagnostic infrastructure in emerging economies
4.2.3 OPPORTUNITIES
4.2.3.1 Integration of AI & ML in veterinary PoC diagnostics
4.2.3.2 Expansion of rapid PoC and portable on-farm diagnostic solutions
4.2.4 CHALLENGES
4.2.4.1 Rapid mutation and strain variability of viral pathogens
4.3 UNMET NEEDS AND WHITE SPACES
4.3.1 UNMET NEEDS IN VETERINARY POC DIAGNOSTICS MARKET
4.3.2 WHITE SPACE OPPORTUNITIES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
4.5.1 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC OUTLOOK
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025
5.5.1.1 Pricing trend of veterinary PoC diagnostic products, by key player, 2023?2025
5.5.2 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY REGION, 2023–2025
5.5.2.1 Pricing trend of PCR kits, by region, 2023?2025
5.5.2.2 Pricing trend of immunodiagnostic veterinary POC products, by region, 2023?2025
5.6 TRADE ANALYSIS
5.6.1 TRADE DATA FOR HS CODE 3822-COMPLIANT PRODUCTS
5.6.1.1 Country-wise import data for HS code 3822-compliant products, 2021–2025
5.6.1.2 Country-wise export data for HS code 3822-compliant products, 2021–2025
5.7 KEY CONFERENCES AND EVENTS, 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 USE OF AI-POWERED POULTRY DISEASE DIAGNOSTICS FOR COCCIDIOSIS & SALMONELLA DETECTION
5.10.2 ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION
5.10.3 DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION
5.11 IMPACT OF US TARIFFS ON VETERINARY POC DIAGNOSTICS MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.5 IMPACT ON END USERS
5.11.5.1 Veterinary hospitals & clinics
5.11.5.2 Livestock producers & animal health networks
5.11.5.3 Home care settings
5.11.5.4 Other end users (mobile veterinary service providers, animal shelters, NGOs)
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1 KEY/EMERGING TECHNOLOGIES
6.1.1 CRISPR-BASED MOLECULAR DIAGNOSTICS
6.1.2 ISOTHERMAL AMPLIFICATION AND PAPER-BASED LAMP
6.2 COMPLEMENTARY TECHNOLOGIES
6.2.1 MICROFLUIDICS & LAB-ON-A-CHIP DEVICES
6.2.2 BIOSENSOR-BASED DIAGNOSTIC SYSTEMS
6.3 ADJACENT TECHNOLOGIES
6.3.1 AI & MACHINE LEARNING
6.3.2 WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES
6.4 TECHNOLOGY/PRODUCT ROADMAP
6.4.1 NEAR TERM (2025–2027)
6.4.2 MID TERM (2028–2030)
6.4.3 LONG TERM (2030+)
6.5 PATENT ANALYSIS
6.5.1 PATENT PUBLICATION TRENDS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
6.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS
6.6 FUTURE APPLICATIONS
6.6.1 PRECISION FLOCK-LEVEL DISEASE PREDICTION
6.6.2 MINI FULLY INTEGRATED ON-FARM MOLECULAR TESTING PLATFORMS
6.6.3 MULTIPLEX AND SYNDROMIC VETERINARY DIAGNOSTIC PANELS
6.6.4 SMART BIOSENSOR-ENABLED REAL-TIME HEALTH MONITORING
6.7 IMPACT OF AI/GENERATIVE AI ON VETERINARY POC DIAGNOSTICS MARKET
6.7.1 INTRODUCTION
6.7.2 MARKET POTENTIAL IN VETERINARY POC DIAGNOSTIC ECOSYSTEM
6.7.3 AI USE CASES
6.7.4 KEY COMPANIES IMPLEMENTING AI IN VETERINARY POC DIAGNOSTICS MARKET
7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1 REGIONAL REGULATIONS AND COMPLIANCE
7.1.1 REGULATORY ANALYSIS
7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.3 INDUSTRY STANDARDS
7.2 SUSTAINABILITY INITIATIVES
7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
7.2.2 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1.1 DECISION-MAKING PROCESS
8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
8.2.2 BUYING CRITERIA
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.3.1 UNMET NEEDS OF VARIOUS END USERS
8.4 MARKET PROFITABILITY
9 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT
9.1 INTRODUCTION
9.2 CONSUMABLES
9.2.1 INCREASING PREVALENCE OF INFECTIOUS AND ZOONOTIC DISEASES IN ANIMALS TO BOOST DEMAND
9.2.2 GLOBAL VOLUME ANALYSIS OF CONSUMABLES, 2024–2031 (THOUSAND UNITS)
9.3 INSTRUMENTS
9.3.1 SURGING DEMAND FOR PORTABLE AND AUTOMATED DIAGNOSTIC SYSTEMS TO ACCELERATE MARKET GROWTH
9.3.2 GLOBAL VOLUME ANALYSIS OF INSTRUMENTS, 2024–2031 (THOUSAND UNITS)
10 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE
10.1 INTRODUCTION
10.2 COMPANION ANIMALS
10.2.1 GROWING PET ADOPTION DUE TO RISING URBANIZATION TO FACILITATE MARKET GROWTH
10.2.2 DOG
10.2.2.1 Increasing prevalence of canine infectious diseases to support rapid adoption of veterinary care
10.2.3 CAT
10.2.3.1 Growing awareness of feline infectious diseases to fuel market growth
10.2.4 HORSE
10.2.4.1 Need to prevent vertical pathogen transmission to stimulate use of extensive PCR surveillance solutions
10.2.5 OTHER COMPANION ANIMALS
10.3 LIVESTOCK
10.3.1 SUSCEPTIBILITY OF LIVESTOCK TO FOOT-AND-MOUTH DISEASE, CLASSICAL SWINE FEVER, AVIAN INFLUENZA TO PROMOTE ADOPTION OF DIAGNOSTIC PRODUCTS
10.3.2 CATTLE
10.3.2.1 Increasing focus on improving milk quality, herd productivity, and biosecurity management to drive demand
10.3.3 PIG
10.3.3.1 Growing swine disease outbreaks to accelerate diagnostic utilization
10.3.4 POULTRY
10.3.4.1 Rrising concerns regarding zoonotic disease transmission to spur demand
10.3.5 OTHER LIVESTOCK
11 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY
11.1 INTRODUCTION
11.2 IMMUNODIAGNOSTICS
11.2.1 PRESSING NEED FOR RAPID AND COST-EFFECTIVE INFECTIOUS DISEASE TESTING TO CONTRIBUTE TO MARKET GROWTH
11.3 MOLECULAR DIAGNOSTICS
11.3.1 PCR-BASED
11.3.1.1 Increasing use of portable and multiplex PCR platforms to propel market
11.3.2 ISOTHERMAL AMPLIFICATION
11.3.2.1 Demand for rapid and low-infrastructure molecular testing to accelerate adoption
11.3.3 CRISPR-BASED
11.3.3.1 Emerging next-generation pathogen detection technologies to create growth potential
11.4 OTHER TECHNOLOGIES
12 VETERINARY POC DIAGNOSTICS MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.2.3 US
12.2.3.1 High veterinary healthcare expenditure to drive market
12.2.4 CANADA
12.2.4.1 Growing pet adoption to drive market
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.3.3 GERMANY
12.3.3.1 Rising awareness of zoonotic diseases to fuel market growth
12.3.4 UK
12.3.4.1 Increasing pet ownership to stimulate demand
12.3.5 FRANCE
12.3.5.1 Willingness of pet owners to spend on pet health to promote market growth
12.3.6 ITALY
12.3.6.1 Growing consumption of meat and dairy products to drive market
12.3.7 SPAIN
12.3.7.1 Growing demand for poultry products to fuel market growth
12.3.8 NETHERLANDS
12.3.8.1 Developments in veterinary diagnostic products to support market growth
12.3.9 POLAND
12.3.9.1 Rapid expansion of poultry production and export-oriented farming to elevate demand
12.3.10 SWEDEN
12.3.10.1 Strong veterinary healthcare infrastructure and advanced animal welfare regulations to propel market
12.3.11 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.4.3 CHINA
12.4.3.1 Increasing incidence of zoonotic diseases to propel market
12.4.4 JAPAN
12.4.4.1 Increasing pet expenditure to support market growth
12.4.5 INDIA
12.4.5.1 Increasing demand for dairy products to drive market
12.4.6 AUSTRALIA
12.4.6.1 Rise in pet ownership to support market growth
12.4.7 SOUTH KOREA
12.4.7.1 Rising need for specialized veterinary services to drive market
12.4.8 NEW ZEALAND
12.4.8.1 Focus on pet insurance to aid market
12.4.9 THAILAND
12.4.9.1 Growing focus on disease surveillance to drive market
12.4.10 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.5.3 BRAZIL
12.5.3.1 Booming livestock industry to boost demand
12.5.4 MEXICO
12.5.4.1 Expanding poultry sector to support market growth
12.5.5 ARGENTINA
12.5.5.1 Expanding poultry production and increasing focus on disease monitoring to drive market
12.5.6 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024–2031
12.6.3 GCC COUNTRIES
12.6.3.1 Kingdom of Saudi Arabia (KSA)
12.6.3.1.1 Technology advancements in veterinary diagnostics to boost demand
12.6.3.2 United Arab Emirates (UAE)
12.6.3.2.1 Favorable government support for vet diagnostics to drive market
12.6.3.3 Rest of GCC Countries
12.6.4 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, JANUARY 2022–APRIL 2026
13.3 REVENUE ANALYSIS, 2021?2025
13.4 MARKET SHARE ANALYSIS, 2025
13.4.1 US MARKET SHARE ANALYSIS, 2025
13.4.2 EUROPE MARKET SHARE ANALYSIS, 2025
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
13.5.1 STARS
13.5.2 EMERGING LEADERS
13.5.3 PERVASIVE PLAYERS
13.5.4 PARTICIPANTS
13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.5.5.1 Company footprint
13.5.5.2 Region footprint
13.5.5.3 Product footprint
13.5.5.4 Technology footprint
13.5.5.5 Animal type footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.6.1 PROGRESSIVE COMPANIES
13.6.2 RESPONSIVE COMPANIES
13.6.3 DYNAMIC COMPANIES
13.6.4 STARTING BLOCKS
13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.6.5.1 Detailed list of key startups/SMEs
13.6.5.2 Competitive benchmarking of key startups/SMEs
13.7 BRAND/PRODUCT COMPARISON
13.8 R&D EXPENDITURE OF KEY PLAYERS
13.9 COMPANY VALUATION AND FINANCIAL METRICS
13.9.1 FINANCIAL METRICS
13.9.2 COMPANY VALUATION
13.10 COMPETITIVE SCENARIO
13.10.1 PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS
13.10.2 DEALS
13.10.3 EXPANSIONS
13.10.4 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 IDEXX LABORATORIES, INC.
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches/Approvals/Enhancements
14.1.1.4 MnM view
14.1.1.4.1 Key strengths
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses & competitive threats
14.1.2 ZOETIS SERVICES LLC
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Deals
14.1.2.3.2 Expansions
14.1.2.3.3 Other developments
14.1.2.4 MnM view
14.1.2.4.1 Key strengths
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses & competitive threats
14.1.3 THERMO FISHER SCIENTIFIC INC.
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 MnM view
14.1.3.3.1 Key strengths
14.1.3.3.2 Strategic choices
14.1.3.3.3 Weaknesses & competitive threats
14.1.4 ANTECH DIAGNOSTICS, INC.
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches/Approvals/Enhancements
14.1.4.3.2 Expansions
14.1.4.4 MnM view
14.1.4.4.1 Key strengths
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses & competitive threats
14.1.5 BIONOTE
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.4 Product launches/Approvals/Enhancements
14.1.5.4.1 Deals
14.1.5.5 MnM view
14.1.5.5.1 Key strengths
14.1.5.5.2 Strategic choices
14.1.5.5.3 Weaknesses & competitive threats
14.1.6 INNOVATIVE DIAGNOSTICS
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Other developments
14.1.7 BIOM?RIEUX
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.7.3 Recent developments
14.1.7.3.1 Product launches/Approvals/Enhancements
14.1.8 INDICAL BIOSCIENCE GMBH
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches/Approvals/Enhancements
14.1.9 VIRBAC
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Deals
14.1.9.3.2 Expansions
14.1.10 MEGACOR DIAGNOSTIK GMBH
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.10.3 Recent developments
14.1.10.3.1 Product launches/Approvals/Enhancements
14.1.11 BIOGAL
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 RING BIOTECHNOLOGY CO., LTD.
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.12.3 Recent developments
14.1.12.3.1 Product launches/Approvals/Enhancements
14.1.12.3.2 Other developments
14.1.13 AGROLABO S.P.A.
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.14 ENALEES
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.14.3 Recent developments
14.1.14.3.1 Product launches/Approvals/Enhancements
14.1.14.3.2 Deals
14.1.14.3.3 Expansions
14.1.14.3.4 Other developments
14.1.15 BIOPANDA REAGENTS LTD
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER PLAYERS
14.2.1 FASSISI, GMBH
14.2.2 SKYER, INC.
14.2.3 GOLD STANDARD DIAGNOSTICS
14.2.4 BIO-X DIAGNOSTICS S.A.
14.2.5 AFFIGEN INC.
14.2.6 ALVEO TECHNOLOGIES
14.2.7 FLUXERGY INC.
14.2.8 WOODLEY EQUIPMENT COMPANY LTD
14.2.9 UBIO BIOTECHNOLOGY SYSTEMS PVT. LTD.
14.2.10 CORIS BIOCONCEPT
15 RESEARCH METHODOLOGY
15.1 RESEARCH APPROACH
15.2 RESEARCH METHODOLOGY DESIGN
15.2.1 SECONDARY RESEARCH
15.2.1.1 Key data from secondary sources
15.2.2 PRIMARY DATA
15.2.2.1 Key data from primary sources
15.2.2.2 Key industry insights
15.3 MARKET SIZE ESTIMATION
15.3.1 BOTTOM-UP APPROACH
15.4 DATA TRIANGULATION
15.5 MARKET SHARE ESTIMATION
15.6 RESEARCH ASSUMPTIONS
15.7 RESEARCH LIMITATIONS
15.7.1 METHODOLOGY-RELATED LIMITATIONS
15.7.2 SCOPE-RELATED LIMITATIONS
15.8 RISK ASSESSMENT
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.3.1 PRODUCT ANALYSIS
16.3.2 COMPANY INFORMATION
16.3.3 GEOGRAPHIC ANALYSIS
16.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
16.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT TYPE
16.3.6 BY PRODUCT TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
16.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
TABLE 2 NUMBER OF US HOUSEHOLDS OWNING PETS, BY ANIMAL TYPE, 2024 (MILLION)
TABLE 3 VETERINARY POC DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 5 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025
TABLE 6 PRICING TREND OF PCR KITS, BY REGION, 2023?2025
TABLE 7 PRICING TREND OF IMMUNODIAGNOSTIC (RAPID TEST) VETERINARY POC PRODUCTS, BY REGION, 2023?2025
TABLE 8 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 10 VETERINARY POC DIAGNOSTICS MARKET: MAJOR CONFERENCES AND EVENTS IN 2026–2027
TABLE 11 CASE STUDY 1: ADVANCED DIAGNOSTIC SOLUTIONS FOR POULTRY DISEASES: TARGETING COCCIDIOSIS AND SALMONELLA DETECTION USING AI TECHNOLOGIES
TABLE 12 CASE STUDY 2: AI-POWERED DIAGNOSTIC PLATFORM WITH DIGITAL MICROSCOPY AND DEEP LEARNING: TARGETING PARASITE DETECTION
TABLE 13 CASE STUDY 3: MULTIPLEX ELISA-BASED POC DIAGNOSTIC TEST: TARGETING VECTOR-BORNE DISEASE DETECTION
TABLE 14 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 15 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 16 NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA
TABLE 17 ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA
TABLE 18 EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK
TABLE 19 LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO
TABLE 20 VETERINARY POC DIAGNOSTICS MARKET: MAJOR PATENTS
TABLE 21 KEY COMPANIES ADOPTING AI-POWERED VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 28 KEY BUYING CRITERIA FOR TOP 3 END USERS
TABLE 29 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 30 VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31 KEY PLAYERS PROVIDING CONSUMABLES
TABLE 32 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 33 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
TABLE 34 KEY PLAYERS PROVIDING INSTRUMENTS
TABLE 35 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
TABLE 37 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 38 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR COMPANION ANIMALS
TABLE 39 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 DOG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 CAT: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 HORSE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 OTHER COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR LIVESTOCK
TABLE 46 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 47 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 CATTLE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 PIG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 POULTRY: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 OTHER LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 53 KEY PLAYERS PROVIDING IMMUNODIAGNOSTICS
TABLE 54 IMMUNODIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS
TABLE 56 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 57 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 PCR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 ISOTHERMAL AMPLIFICATION MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 CRISPR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 OTHER TECHNOLOGIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 63 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 64 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 66 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 67 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 68 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 69 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 70 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 71 US: KEY MACRO INDICATORS
TABLE 72 US: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 73 US: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 74 US: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 75 US: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 76 US: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 77 US: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 78 CANADA: KEY MACRO INDICATORS
TABLE 79 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 80 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 81 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 82 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 83 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 84 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 85 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 86 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 88 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 89 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 90 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 91 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 92 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 93 GERMANY: KEY MACRO INDICATORS
TABLE 94 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 95 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 96 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 97 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 98 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 99 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 100 UK: KEY MACRO INDICATORS
TABLE 101 UK: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 102 UK: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 103 UK: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 104 UK: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 105 UK: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 106 UK: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 107 FRANCE: KEY MACRO INDICATORS
TABLE 108 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 109 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 110 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 111 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 112 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 113 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 114 ITALY: KEY MACRO INDICATORS
TABLE 115 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 116 ITALY VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 117 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 118 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 119 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 120 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 121 SPAIN: KEY MACRO INDICATORS
TABLE 122 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 123 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 124 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 125 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 126 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 127 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 128 NETHERLANDS: KEY MACRO INDICATORS
TABLE 129 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 130 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 131 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 132 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 133 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 134 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 135 POLAND: KEY MACRO INDICATORS
TABLE 136 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 137 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 138 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 139 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 140 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 141 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 142 SWEDEN: KEY MACRO INDICATORS
TABLE 143 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 144 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 145 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 146 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 147 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 148 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 149 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 150 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 151 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 152 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 153 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 154 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 155 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 156 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 158 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 159 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 161 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 162 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 163 CHINA: KEY MACRO INDICATORS
TABLE 164 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 165 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 166 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 167 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 168 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 169 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 170 JAPAN: KEY MACRO INDICATORS
TABLE 171 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 172 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 173 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 174 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 175 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 176 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 177 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 178 INDIA: KEY MACRO INDICATORS
TABLE 179 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 180 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 181 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 182 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 183 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 184 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 185 AUSTRALIA: KEY MACRO INDICATORS
TABLE 186 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 187 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 188 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 189 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 190 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 191 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 192 SOUTH KOREA: KEY MACRO INDICATORS
TABLE 193 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 194 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 195 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 196 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 197 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 198 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 199 NEW ZEALAND: KEY MACRO INDICATORS
TABLE 200 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 201 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 202 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 203 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 204 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 205 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
TABLE 2 NUMBER OF US HOUSEHOLDS OWNING PETS, BY ANIMAL TYPE, 2024 (MILLION)
TABLE 3 VETERINARY POC DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 4 GDP CHANGE, BY KEY COUNTRY, 2021–2030 (USD BILLION)
TABLE 5 PRICING TREND OF VETERINARY POC DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023–2025
TABLE 6 PRICING TREND OF PCR KITS, BY REGION, 2023?2025
TABLE 7 PRICING TREND OF IMMUNODIAGNOSTIC (RAPID TEST) VETERINARY POC PRODUCTS, BY REGION, 2023?2025
TABLE 8 IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 9 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 10 VETERINARY POC DIAGNOSTICS MARKET: MAJOR CONFERENCES AND EVENTS IN 2026–2027
TABLE 11 CASE STUDY 1: ADVANCED DIAGNOSTIC SOLUTIONS FOR POULTRY DISEASES: TARGETING COCCIDIOSIS AND SALMONELLA DETECTION USING AI TECHNOLOGIES
TABLE 12 CASE STUDY 2: AI-POWERED DIAGNOSTIC PLATFORM WITH DIGITAL MICROSCOPY AND DEEP LEARNING: TARGETING PARASITE DETECTION
TABLE 13 CASE STUDY 3: MULTIPLEX ELISA-BASED POC DIAGNOSTIC TEST: TARGETING VECTOR-BORNE DISEASE DETECTION
TABLE 14 US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 15 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 16 NORTH AMERICA: IMPACT OF US TARIFFS ON CANADA
TABLE 17 ASIA PACIFIC: IMPACT OF US TARIFFS ON CHINA, JAPAN, AND INDIA
TABLE 18 EUROPE: IMPACT OF US TARIFFS ON GERMANY AND UK
TABLE 19 LATIN AMERICA: IMPACT OF US TARIFFS ON MEXICO
TABLE 20 VETERINARY POC DIAGNOSTICS MARKET: MAJOR PATENTS
TABLE 21 KEY COMPANIES ADOPTING AI-POWERED VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 22 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 23 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 24 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
TABLE 28 KEY BUYING CRITERIA FOR TOP 3 END USERS
TABLE 29 VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 30 VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 31 KEY PLAYERS PROVIDING CONSUMABLES
TABLE 32 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 33 CONSUMABLES: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
TABLE 34 KEY PLAYERS PROVIDING INSTRUMENTS
TABLE 35 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 36 INSTRUMENTS: VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (THOUSAND UNITS)
TABLE 37 VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 38 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR COMPANION ANIMALS
TABLE 39 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 40 COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 41 DOG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 CAT: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 43 HORSE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 44 OTHER COMPANION ANIMALS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 KEY PLAYERS PROVIDING VETERINARY POC DIAGNOSTICS FOR LIVESTOCK
TABLE 46 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 47 LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 CATTLE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 49 PIG: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 50 POULTRY: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 OTHER LIVESTOCK: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 52 VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 53 KEY PLAYERS PROVIDING IMMUNODIAGNOSTICS
TABLE 54 IMMUNODIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 55 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS
TABLE 56 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 57 MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 58 PCR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 59 ISOTHERMAL AMPLIFICATION MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 CRISPR-BASED MOLECULAR DIAGNOSTICS: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 OTHER TECHNOLOGIES: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 62 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 63 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 64 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 65 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 66 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 67 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 68 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 69 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 70 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 71 US: KEY MACRO INDICATORS
TABLE 72 US: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 73 US: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 74 US: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 75 US: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 76 US: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 77 US: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 78 CANADA: KEY MACRO INDICATORS
TABLE 79 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 80 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 81 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 82 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 83 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 84 CANADA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 85 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 86 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 88 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 89 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 90 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 91 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 92 EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 93 GERMANY: KEY MACRO INDICATORS
TABLE 94 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 95 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 96 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 97 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 98 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 99 GERMANY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 100 UK: KEY MACRO INDICATORS
TABLE 101 UK: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 102 UK: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 103 UK: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 104 UK: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 105 UK: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 106 UK: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 107 FRANCE: KEY MACRO INDICATORS
TABLE 108 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 109 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 110 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 111 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 112 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 113 FRANCE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 114 ITALY: KEY MACRO INDICATORS
TABLE 115 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 116 ITALY VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 117 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 118 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 119 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 120 ITALY: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 121 SPAIN: KEY MACRO INDICATORS
TABLE 122 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 123 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 124 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 125 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 126 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 127 SPAIN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 128 NETHERLANDS: KEY MACRO INDICATORS
TABLE 129 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 130 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 131 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 132 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 133 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 134 NETHERLANDS: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 135 POLAND: KEY MACRO INDICATORS
TABLE 136 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 137 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 138 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 139 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 140 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 141 POLAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 142 SWEDEN: KEY MACRO INDICATORS
TABLE 143 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 144 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 145 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 146 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 147 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 148 SWEDEN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 149 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 150 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 151 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 152 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 153 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 154 REST OF EUROPE: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 155 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (THOUSAND UNITS)
TABLE 156 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 157 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 158 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 159 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 160 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 161 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 162 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 163 CHINA: KEY MACRO INDICATORS
TABLE 164 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 165 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 166 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 167 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 168 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 169 CHINA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 170 JAPAN: KEY MACRO INDICATORS
TABLE 171 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 172 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 173 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 174 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 175 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 176 JAPAN: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 177 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)
TABLE 178 INDIA: KEY MACRO INDICATORS
TABLE 179 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 180 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 181 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 182 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 183 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 184 INDIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 185 AUSTRALIA: KEY MACRO INDICATORS
TABLE 186 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 187 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 188 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 189 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 190 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 191 AUSTRALIA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 192 SOUTH KOREA: KEY MACRO INDICATORS
TABLE 193 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 194 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 195 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 196 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 197 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 198 SOUTH KOREA: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
TABLE 199 NEW ZEALAND: KEY MACRO INDICATORS
TABLE 200 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY PRODUCT, 2024–2031 (USD MILLION)
TABLE 201 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 202 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY COMPANION ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 203 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY LIVESTOCK TYPE, 2024–2031 (USD MILLION)
TABLE 204 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
TABLE 205 NEW ZEALAND: VETERINARY POC DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2024–2031 (USD MILLION)
LIST OF FIGURES
FIGURE 1 VETERINARY POC DIAGNOSTICS MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2020–2025
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VETERINARY POC DIAGNOSTICS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN VETERINARY POC DIAGNOSTICS MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VETERINARY POC DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8 INCREASING DEMAND FOR RAPID AND ON-SITE DIAGNOSTICS TO FUEL MARKET GROWTH
FIGURE 9 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 10 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 13 VETERINARY POC DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 PET EXPENDITURE IN US, DOGS VS. CATS, 2024 (USD)
FIGURE 15 VETERINARY POC DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 16 VETERINARY POC DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 17 VETERINARY POC DIAGNOSTIC ECOSYSTEM ANALYSIS
FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 19 VETERINARY POC DIAGNOSTICS MARKET: INVESTMENT AND FUNDING SCENARIO
FIGURE 20 VETERINARY POC DIAGNOSTICS MARKET: NUMBER OF PATENTS GRANTED AND APPLIED (JANUARY 2015–MAY 2026)
FIGURE 21 TOP APPLICANT COUNTRIES AND REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2015–FEBRUARY 2026)
FIGURE 22 ADOPTION OF AI-POWERED DIAGNOSTIC SOLUTIONS FOR DISEASE TREND IDENTIFICATION AND TREATMENT OPTIMIZATION
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
FIGURE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS
FIGURE 25 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 26 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012–2030
FIGURE 27 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT
FIGURE 28 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 29 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 30 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2021?2025)
FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 33 US MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 34 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 35 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 36 VETERINARY POC DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 37 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 38 VETERINARY POC DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2022?2025
FIGURE 40 EV/EBITDA OF KEY VENDORS
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 43 ZOETIS SERVICES LLC: COMPANY SNAPSHOT
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 45 BIOM?RIEUX: COMPANY SNAPSHOT
FIGURE 46 VIRBAC: COMPANY SNAPSHOT
FIGURE 47 VETERINARY POC DIAGNOSTICS MARKET: RESEARCH DESIGN
FIGURE 48 DATA OBTAINED FROM SECONDARY SOURCES
FIGURE 49 PRIMARY SOURCES
FIGURE 50 DATA OBTAINED FROM PRIMARY SOURCES
FIGURE 51 EXPERT INSIGHTS
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 55 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 56 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 57 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY POC DIAGNOSTICS MARKET (2024)
FIGURE 58 VETERINARY POC DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 59 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY POC DIAGNOSTICS MARKET (2026–2031)
FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 61 TOP-DOWN APPROACH
FIGURE 62 BOTTOM-UP APPROACH
FIGURE 63 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 1 VETERINARY POC DIAGNOSTICS MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 2 MARKET SCENARIO
FIGURE 3 GLOBAL VETERINARY POC DIAGNOSTICS MARKET, 2024–2031
FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2020–2025
FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF VETERINARY POC DIAGNOSTICS MARKET
FIGURE 6 HIGH-GROWTH SEGMENTS IN VETERINARY POC DIAGNOSTICS MARKET, 2026–2031
FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN VETERINARY POC DIAGNOSTICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
FIGURE 8 INCREASING DEMAND FOR RAPID AND ON-SITE DIAGNOSTICS TO FUEL MARKET GROWTH
FIGURE 9 CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2025
FIGURE 10 ASIA PACIFIC TO EXHIBIT HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 12 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
FIGURE 13 VETERINARY POC DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 14 PET EXPENDITURE IN US, DOGS VS. CATS, 2024 (USD)
FIGURE 15 VETERINARY POC DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 16 VETERINARY POC DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS
FIGURE 17 VETERINARY POC DIAGNOSTIC ECOSYSTEM ANALYSIS
FIGURE 18 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 19 VETERINARY POC DIAGNOSTICS MARKET: INVESTMENT AND FUNDING SCENARIO
FIGURE 20 VETERINARY POC DIAGNOSTICS MARKET: NUMBER OF PATENTS GRANTED AND APPLIED (JANUARY 2015–MAY 2026)
FIGURE 21 TOP APPLICANT COUNTRIES AND REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2015–FEBRUARY 2026)
FIGURE 22 ADOPTION OF AI-POWERED DIAGNOSTIC SOLUTIONS FOR DISEASE TREND IDENTIFICATION AND TREATMENT OPTIMIZATION
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VETERINARY POC DIAGNOSTIC PRODUCTS
FIGURE 24 KEY BUYING CRITERIA FOR TOP 3 END USERS
FIGURE 25 VETERINARY POC DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 26 EXPECTED GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA, 2012–2030
FIGURE 27 NORTH AMERICA: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT
FIGURE 28 ASIA PACIFIC: DOG POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 29 ASIA PACIFIC: CAT POPULATION GROWTH, BY COUNTRY, 2024
FIGURE 30 ASIA PACIFIC: VETERINARY POC DIAGNOSTICS MARKET SNAPSHOT
FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2021?2025)
FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 33 US MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 34 EUROPE MARKET SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET (2025)
FIGURE 35 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
FIGURE 36 VETERINARY POC DIAGNOSTICS MARKET: COMPANY FOOTPRINT
FIGURE 37 VETERINARY POC DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
FIGURE 38 VETERINARY POC DIAGNOSTICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 39 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY POC DIAGNOSTICS MARKET, 2022?2025
FIGURE 40 EV/EBITDA OF KEY VENDORS
FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 43 ZOETIS SERVICES LLC: COMPANY SNAPSHOT
FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
FIGURE 45 BIOM?RIEUX: COMPANY SNAPSHOT
FIGURE 46 VIRBAC: COMPANY SNAPSHOT
FIGURE 47 VETERINARY POC DIAGNOSTICS MARKET: RESEARCH DESIGN
FIGURE 48 DATA OBTAINED FROM SECONDARY SOURCES
FIGURE 49 PRIMARY SOURCES
FIGURE 50 DATA OBTAINED FROM PRIMARY SOURCES
FIGURE 51 EXPERT INSIGHTS
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION (SUPPLY SIDE)
FIGURE 53 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION (DEMAND SIDE)
FIGURE 54 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 55 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 56 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.
FIGURE 57 REVENUE ANALYSIS OF TOP 5 COMPANIES: VETERINARY POC DIAGNOSTICS MARKET (2024)
FIGURE 58 VETERINARY POC DIAGNOSTICS MARKET: DEMAND-SIDE ANALYSIS
FIGURE 59 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF VETERINARY POC DIAGNOSTICS MARKET (2026–2031)
FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 61 TOP-DOWN APPROACH
FIGURE 62 BOTTOM-UP APPROACH
FIGURE 63 MARKET DATA TRIANGULATION METHODOLOGY
